Details of the Drug

General Information of Drug (ID: DMKDGI8)

Drug Name
BP-100-1-01
Indication
Disease Entry ICD 11 Status REF
Acute lymphoblastic leukaemia 2A85 Phase 2 [1]
Acute myeloid leukaemia 2A60 Phase 2 [1]
Chronic myelogenous leukaemia 2A20.0 Phase 2 [1]
Hematologic tumour 2B33.Y Phase 2 [1]
Myelodysplastic syndrome 2A37 Phase 2 [1]
Cross-matching ID
TTD ID
D0L3KA
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
GRB2 messenger RNA (GRB2 mRNA) TTEYRJ9 GRB2_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032443)
2 ClinicalTrials.gov (NCT01159028) Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS. U.S. National Institutes of Health.